Berobenatide is one of the keys to Pfizer's future.

Pfizer carries one of Big Pharma's fattest yields while Merck burns cash on deals to secure its next growth era. Which ...

Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.

NEW YORK (PIX11) — If you ever purchased Chantix, a drug meant to help people quit tobacco and stop smoking, you may be owed ...

The company reiterated its recent reduction in full-year sales guidance by $9 billion as it doubled down on efforts to trim ...

The stock's yield is more than six times the S&P 500 average.

Pfizer will reduce its costs by $2.5 billion in another round of cutbacks, which will kick in next year and run through 2029. The New York company unveiled the plan in its second-quarter earnings ...

Pfizer’s PFE third-quarter revenue fell 6%, as acquisition charges outweighed cost efficiencies and pushed adjusted diluted EPS down 18%. In the battle for Metsera’s obesity pipeline, Pfizer announced ...

Construction delays at MetroLoft's conversion of the Pfizer building could endanger success at the Midtown East project ...